UPXI Straddle Strategy
UPXI (Upexi, Inc.), in the Consumer Defensive sector, (Household & Personal Products industry), listed on NASDAQ.
Upexi, Inc. engages in the development, manufacture, and distribution of consumer products. It offers nail grinder and healthy all-natural pet supplements under the LuckyTail brand; energy solutions under the PRAX brand; functional mushrooms under the Cure Mushrooms brand; cannabinoid under the Moonwlkr brand; and gummies and other products under the Gumi Labs brand name. The company sells its products through direct-to-consumer network, wholesale partnerships, and third-party platform. It also focuses on cryptocurrency industry and management of cash assets. The company was formerly known as Grove, Inc. and changed its name to Upexi, Inc. in August 2022. Upexi, Inc. was incorporated in 2018 and is headquartered in Tampa, Florida.
UPXI (Upexi, Inc.) trades in the Consumer Defensive sector, specifically Household & Personal Products, with a market capitalization of approximately $54.9M, a beta of -0.24 versus the broader market, a 52-week range of 0.54-9.115, average daily share volume of 2.3M, a public-listing history dating back to 2021, approximately 59 full-time employees. These structural characteristics shape how UPXI stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of -0.24 indicates UPXI has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure.
What is a straddle on UPXI?
A long straddle buys an ATM call and an ATM put at the same strike, profiting from a large move in either direction; max loss equals the combined debit when the underlying pins to the strike at expiration.
UPXI snapshot
As of August 14, 2026, spot at $0.75, ATM IV 155.46%, IV rank 30.94%, expected move 44.57%. The straddle on UPXI below is built from the end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 28-day expiry.
Why this straddle structure on UPXI specifically: UPXI IV at 155.46% is mid-range versus its 1-year history, so strategy selection should anchor more to the directional thesis than to the IV regime, with a market-implied 1-standard-deviation move of approximately 44.57% (roughly $0.33 on the underlying). The 28-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated UPXI expiries trade a higher absolute premium for lower per-day decay. Position sizing on UPXI should anchor to the underlying notional of $0.75 per share and to the trader's directional view on UPXI stock.
UPXI straddle setup
The UPXI straddle below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With UPXI at $0.75 on that close, the first option leg uses a $0.75 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed UPXI chain at a 28-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 UPXI shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $0.75 | N/A |
| Buy 1 | Put | $0.75 | N/A |
UPXI straddle risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Upside max profit is unbounded; downside max profit is bounded at the strike minus the combined call plus put debit (reached at zero). Max loss equals the combined debit times 100 (reached when the underlying pins to the strike). Two breakevens at strike plus debit and strike minus debit.
UPXI straddle payoff curve
Modeled P&L at expiration across a range of underlying prices for the straddle on UPXI. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use straddle on UPXI
Straddles on UPXI are pure-volatility plays that profit from large moves in either direction; traders typically buy UPXI straddles ahead of earnings, FDA decisions, or other catalysts where the realized move is expected to exceed the implied move priced into the chain.
UPXI thesis for this straddle
The market-implied 1-standard-deviation range for UPXI extends from approximately $0.42 on the downside to $1.08 on the upside. A UPXI long straddle is a pure-volatility play: it profits when the underlying moves far enough from the strike in either direction to overcome the combined call plus put debit, regardless of direction. Current UPXI IV rank near 30.94% is mid-range against its 1-year distribution, so the IV signal is neutral; the straddle thesis on UPXI should anchor more to the directional view and the expected-move geometry. As a Consumer Defensive name, UPXI options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to UPXI-specific events.
UPXI straddle positions are structurally neutral / high-volatility (long premium); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. UPXI positions also carry Consumer Defensive sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move UPXI alongside the broader basket even when UPXI-specific fundamentals are unchanged. Always rebuild the position from current UPXI chain quotes before placing a trade.
Frequently asked questions
- What is a straddle on UPXI?
- A straddle on UPXI is the straddle strategy applied to UPXI (stock). The strategy is structurally neutral / high-volatility (long premium): A long straddle buys an ATM call and an ATM put at the same strike, profiting from a large move in either direction; max loss equals the combined debit when the underlying pins to the strike at expiration. With UPXI stock at $0.75 on the most recent close, the strikes shown on this page are snapped to the nearest listed UPXI chain strike and the premiums come straight from that session's bid/ask midpoint.
- How are UPXI straddle max profit and max loss calculated?
- Upside max profit is unbounded; downside max profit is bounded at the strike minus the combined call plus put debit (reached at zero). Max loss equals the combined debit times 100 (reached when the underlying pins to the strike). Two breakevens at strike plus debit and strike minus debit. For the UPXI straddle priced from the end-of-day chain at a 30-day expiry (ATM IV 155.46%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a UPXI straddle?
- The breakeven for the UPXI straddle priced on this page is no defined breakeven on the modeled curve at expiration, derived from the end-of-day chain's premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The UPXI market-implied 1-standard-deviation expected move in the same options snapshot is approximately 44.57%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a straddle on UPXI?
- Straddles on UPXI are pure-volatility plays that profit from large moves in either direction; traders typically buy UPXI straddles ahead of earnings, FDA decisions, or other catalysts where the realized move is expected to exceed the implied move priced into the chain.
- How does current UPXI implied volatility affect this straddle?
- UPXI ATM IV is at 155.46% with IV rank near 30.94%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.